Physician profile
Sridhar Reddy
NPI 1033268040
$21,457.84
in general payments reported to CMS, 2019-2025
63 companies · $3,079 in 2025
The $3,079 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,296 · 2021: $1,334 · 2022: $1,311 · 2023: $1,151 · 2024: $1,194 · 2025: $3,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,651 · Consulting Fee: $1,664 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,650.54 |
| Consulting Fee | $1,664.00 |
| Education | $109.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11,003.25 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $1,664.00 | 2025 | Dupixent |
| Novo Nordisk INC | $924.79 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $693.91 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Abbvie INC. | $632.37 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $512.07 | 2019-2021 | |
| Astellas Pharma US INC | $510.95 | 2019-2025 | Veozah, Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $482.54 | 2019-2025 | Eliquis, Cobenfy |
| Novartis Pharmaceuticals Corporation | $417.34 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $411.60 | 2020-2025 | Acthar, Terlivaz |
| Pfizer INC. | $373.65 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $345.24 | 2020-2025 | Farxiga, Lokelma, Breztri |
| Otsuka America Pharmaceutical, INC. | $306.10 | 2019-2025 | Jynarque, Nuedexta |
| Bayer Healthcare Pharmaceuticals INC. | $242.94 | 2022-2025 | |
| Lilly USA, LLC | $222.03 | 2021-2025 | Mounjaro, Amyvid, Kisunla |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $135.54 | 2025 | Purified Cortrophin Gel |
| Aimmune Therapeutics, INC. | $130.03 | 2024-2025 | Zenpep |
| Abbott Laboratories | $126.77 | 2022-2025 | Xience Skypoint, Eterna, Nc Trek Neo |
| Eisai INC. | $122.77 | 2020-2022 | |
| Gilead Sciences, INC. | $111.69 | 2022-2024 | |
| Avanir Pharmaceuticals, INC. | $106.05 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $98.74 | 2022-2023 | Seglentis |
| Stryker Corporation | $96.56 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sunovion Pharmaceuticals INC. | $94.43 | 2019-2021 | |
| Biogen, INC. | $93.45 | 2020-2022 | |
| Daiichi Sankyo INC. | $90.99 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $87.17 | 2019-2024 | Dificid |
| Nestle Healthcare Nutrition INC. | $81.37 | 2021-2023 | |
| Seqirus USA INC | $79.46 | 2024-2025 | Flucelvax, Fluad |
| Alnylam Pharmaceuticals INC. | $72.14 | 2023 | Givlaari, Amvuttra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.70 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $67.70 | 2021 | |
| Dexcom, INC. | $64.96 | 2023-2024 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $63.41 | 2020-2021 | |
| Exact Sciences Corporation | $62.23 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $56.97 | 2022 | |
| Medtronic, INC. | $55.49 | 2021-2025 | Symplicity G3 |
| Vifor Pharma, INC. | $53.09 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $48.60 | 2023-2024 | Gemtesa |
| Lucid Diagnostics INC. | $47.90 | 2023-2024 | |
| Ossur Americas, INC. | $43.29 | 2025 | |
| Abiomed | $42.12 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.72 | 2021-2023 | Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $40.24 | 2019-2025 | Arexvy, Shingrix |
| Allergan, INC. | $36.37 | 2020 | |
| Scilex Pharmaceuticals INC. | $33.00 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $32.91 | 2024 | Ultomiris |
| Ge Healthcare | $31.45 | 2019 | |
| Boston Scientific Corporation | $30.04 | 2022-2025 | General - Pain Management |
| Insmed, INC. | $24.81 | 2025 | Brinsupri, Arikayce |
| Sanofi-Aventis U.S. LLC | $24.53 | 2021 | |
| Shire North American Group INC | $23.04 | 2019 | |
| Recordati_rare_diseases_inc. | $23.01 | 2024 | Signifor Lar, Isturisa |
| Kyowa Kirin, INC. | $20.98 | 2023 | Crysvita |
| Calliditas Therapeutics US INC. | $20.62 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.33 | 2021 | |
| Xeris Pharmaceuticals, INC. | $18.05 | 2021 | |
| Sanofi Pasteur INC. | $16.58 | 2019 | |
| Edwards Lifesciences Corporation | $15.99 | 2022 | |
| Acadia Pharmaceuticals INC | $15.01 | 2022 | |
| Hikma Pharmaceuticals USA | $14.80 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.77 | 2023 | Quviviq |
| Baxter Healthcare | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridhar Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.